- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ENHANZE (rHuPH20)
Total 1972 results
-
argenxCompletedHealthy VolunteersNetherlands
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerSpain, Argentina, China, France, Turkey, Brazil, Korea, Republic of, Mexico, Chile, Guatemala, Peru, Thailand, Costa Rica, United Kingdom, New Zealand, Hungary, Latvia, Russian Federation, South Africa, Ukraine, Italy, Greece, Poland
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
argenxCompleted
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedLymphedema | Malignant NeoplasmUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Mexico, Italy, Argentina, Brazil, Chile, France, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
PfizerHalozyme TherapeuticsTerminatedHealthy | HypercholesterolemiaBelgium
-
UMC UtrechtUnknown
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Halozyme TherapeuticsCompletedDermatitis, Allergic ContactUnited States
-
Alexion PharmaceuticalsCompletedHealthyUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Completed
-
ViiV HealthcareGlaxoSmithKlineNot yet recruiting
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathySpain, Canada, Poland, Italy, Serbia, Germany, Mexico, Turkey, United Kingdom, Czechia, France, United States, Argentina, Brazil, Colombia, Denmark, Greece, Slovakia
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
Bristol-Myers SquibbRecruitingMelanomaSpain, United States, Italy, Chile, Greece, Argentina
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis (MS)United States
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Baxter Healthcare CorporationHalozyme TherapeuticsCompleted
-
Weill Medical College of Cornell UniversityGreen Chimneys Residential Treatment Center, Brewster, NYCompletedChildhood AggressionUnited States
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Halozyme TherapeuticsCompletedRisk Factors for or a Diagnosis of OsteoporosisUnited States
-
Baxter Healthcare CorporationHalozyme TherapeuticsTerminated
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Israel, Canada, Spain, Czechia, Croatia, Poland, Italy, Serbia, Germany, Argentina, Mexico, Turkey, United Kingdom, Brazil, France, Greece, Slovakia, Colombia, Denmark, Norway, Sweden
-
TakedaTakeda Development Center Americas, Inc.RecruitingPrimary Immunodeficiency Diseases (PID)United States
-
University of WashingtonCenters for Disease Control and PreventionRecruitingArthritis | Osteoarthritis | Rheumatoid Arthritis | Fibromyalgia | Gout | Lupus or SLEUnited States
-
Halozyme TherapeuticsCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingOropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | Hypopharynx CancerUnited States
-
Fenway Community HealthNational Institute of Mental Health (NIMH)CompletedHIV InfectionsUnited States
-
Yale UniversityCompletedType 1 DiabetesUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedCannabis Use DisorderUnited States
-
Halozyme TherapeuticsCompleted
-
Bristol-Myers SquibbCompletedMalignant Solid TumorUnited States, France, Italy, Australia, Canada, Germany, Netherlands
-
University of WashingtonCompletedMultiple Sclerosis | Muscular Dystrophy | Spinal Cord Injury | Post-polio SyndromeUnited States
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Alexion Pharmaceuticals, Inc.Completed
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
Bristol-Myers SquibbRecruitingMelanomaUnited States, Canada, Switzerland, Italy, Spain, Australia, France, Belgium, Finland, Israel, Germany, Sweden, Argentina, Brazil, Colombia, Mexico, Norway, Chile, United Kingdom, Austria, Poland, Czechia
-
Bristol-Myers SquibbRecruitingClear Cell Renal Cell CarcinomaRussian Federation, New Zealand, United States, Finland, France, Ireland, Italy, Turkey, Poland, Argentina, Brazil, Chile, Czechia, Mexico, Portugal, Romania, Spain